Harpoon (HARP) Snares Last Minute Share Surge After Positive Phase I Data
Harpoon Therapeutics (NASDAQ:HARP), a biotechnology company developing an antibody platform [...]
Harpoon (HARP) Data Announcement Scheduled for May 29
Harpoon Therapeutics (NASDAQ:HARP) said last week it would present interim [...]
-
Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020 GalleryAcceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020
Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates
Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020
Onconova Coverage suspended, Oragenics falls short in Phase II trial. [...]